(Q43693161)
Statements
1 reference
Serum pharmacokinetics and sputum penetration of amikacin 30 mg/kg once daily and of ceftazidime 200 mg/kg/day as a continuous infusion in cystic fibrosis patients (English)
1 reference
Byl B
1 reference
Baran D
1 reference
Jacobs F
1 reference
Herschuelz A
1 reference
Thys JP
1 reference
1 August 2001
1 reference
1 reference
Identifiers
1 reference